[Peroperative bleeding in polycythemic patients].
D001062:Appendectomy / Q000009:adverse effects; D001772:Blood Cell Count; D002763:Cholecystectomy / Q000009:adverse effects; D003911:Dextrans / Q000627:therapeutic use; D004791:Enzyme Inhibitors; D005260:Female; D005340:Fibrinogen / Q000627:therapeutic use; D005342:Fibrinolysis; D006406:Hematoma / Q000209:etiology; D006470:Hemorrhage / Q000209:etiology*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy / Q000009:adverse effects; D011086:Polycythemia / Q000601:surgery*; D011087:Polycythemia Vera / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D011183:Postoperative Complications; D013916:Thrombelastography
D003911:Dextrans; D004791:Enzyme Inhibitors; D005340:Fibrinogen; D006493:Heparin
Saignement per-opératoire chez le polycythémique.